JPS6063203A - 新規なキシランスルフエ−ト，その製法並びにその抗血栓症および血中脂肪低下活性 - Google Patents

新規なキシランスルフエ−ト，その製法並びにその抗血栓症および血中脂肪低下活性

Info

Publication number
JPS6063203A
JPS6063203A JP59057193A JP5719384A JPS6063203A JP S6063203 A JPS6063203 A JP S6063203A JP 59057193 A JP59057193 A JP 59057193A JP 5719384 A JP5719384 A JP 5719384A JP S6063203 A JPS6063203 A JP S6063203A
Authority
JP
Japan
Prior art keywords
molecular weight
xylan
sulfation
apparent molecular
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59057193A
Other languages
English (en)
Japanese (ja)
Inventor
アレン　バヨール
ジヤクリーヌ　ランセン
ジヤン　ピエール　マフラン
ジヤン　マリー　ペレイロ
エリツク　ヴアレー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Anic SpA
Original Assignee
Sanofi SA
Anic SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA, Anic SpA filed Critical Sanofi SA
Publication of JPS6063203A publication Critical patent/JPS6063203A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/14—Hemicellulose; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0057—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Xylans, i.e. xylosaccharide, e.g. arabinoxylan, arabinofuronan, pentosans; (beta-1,3)(beta-1,4)-D-Xylans, e.g. rhodymenans; Hemicellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
JP59057193A 1983-03-24 1984-03-24 新規なキシランスルフエ−ト，その製法並びにその抗血栓症および血中脂肪低下活性 Pending JPS6063203A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8305170 1983-03-24
FR8305170A FR2543145B1 (fr) 1983-03-24 1983-03-24 Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante

Publications (1)

Publication Number Publication Date
JPS6063203A true JPS6063203A (ja) 1985-04-11

Family

ID=9287351

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59057193A Pending JPS6063203A (ja) 1983-03-24 1984-03-24 新規なキシランスルフエ−ト，その製法並びにその抗血栓症および血中脂肪低下活性

Country Status (16)

Country Link
US (1) US4699900A (en, 2012)
EP (1) EP0125152B1 (en, 2012)
JP (1) JPS6063203A (en, 2012)
KR (1) KR860001394B1 (en, 2012)
AT (1) ATE24520T1 (en, 2012)
AU (1) AU561588B2 (en, 2012)
CA (1) CA1221090A (en, 2012)
DE (1) DE3461808D1 (en, 2012)
DK (1) DK55784A (en, 2012)
ES (1) ES8500962A1 (en, 2012)
FR (1) FR2543145B1 (en, 2012)
GR (1) GR79831B (en, 2012)
IL (1) IL70846A0 (en, 2012)
NZ (1) NZ207622A (en, 2012)
PT (1) PT78179B (en, 2012)
ZA (1) ZA842176B (en, 2012)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019054344A1 (ja) * 2017-09-12 2019-03-21 王子ホールディングス株式会社 ポリ硫酸ペントサン及びポリ硫酸ペントサンの製造方法
WO2019124363A1 (ja) * 2017-12-20 2019-06-27 王子ホールディングス株式会社 ポリ硫酸ペントサン及びポリ硫酸ペントサンを含む医薬
US11274165B2 (en) 2017-02-28 2022-03-15 Oji Holdings Corporation Pentosan polysulfate, pharmaceutical composition, and anticoagulant
US11278485B2 (en) 2017-05-31 2022-03-22 Oji Holdings Corporation Moisturizing topical preparation
US11286272B2 (en) 2016-08-31 2022-03-29 Oji Holdings Corporation Production method for acidic xylooligosaccharide, and acidic xylooligosaccharide
US11312790B2 (en) 2016-08-31 2022-04-26 Oji Holdings Corporation Production method for pentosan polysulfate

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2543145B1 (fr) * 1983-03-24 1986-10-17 Sanofi Sa Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante
FR2572731B1 (fr) * 1984-11-07 1987-03-06 Sanofi Sa Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale
FR2574663B1 (fr) * 1984-12-17 1987-01-16 Sanofi Sa Nouvelle composition therapeutique a activite antithrombotique et hypolipemiante a base de xylanes et d'un acide organique
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
US5017565A (en) * 1989-04-20 1991-05-21 Lange Iii Louis G Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase
US5484777A (en) * 1989-04-20 1996-01-16 Lange, Iii; Louis G. Pancreatic cholesterol esterase inhibitor
DE3917982A1 (de) * 1989-06-02 1990-12-06 Behringwerke Ag Verwendung von xylanpolyhydrogensulfaten zur therapie von zellproliferations-bedingten erkrankungen
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
US5141928B1 (en) * 1989-12-20 1995-11-14 Brujo Inc Ophthalmic medication
US5382570A (en) * 1990-04-23 1995-01-17 Akzo, N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
US5668274A (en) * 1991-04-23 1997-09-16 Akzo Nobel N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
US5639469A (en) * 1994-06-15 1997-06-17 Minnesota Mining And Manufacturing Company Transmucosal delivery system
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
US20070141181A1 (en) * 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6797289B2 (en) * 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6451771B1 (en) 1999-02-12 2002-09-17 Nutramax Laboratories, Inc. Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals
ES2251289B1 (es) * 2004-02-27 2007-07-01 Bioiberica, S.A. Nuevo uso terapeutico de un grupo de polisacaridos sulfatados.
WO2009047699A1 (en) * 2007-10-10 2009-04-16 Alembic Limited An improved process for the preparation of an amorphous form of pentosan polysulfate or salts thereof
AU2008100725B4 (en) * 2008-07-04 2008-10-02 Parnell Technologies Pty Ltd A sulfated polysaccharide compound for clinical use
WO2011088418A2 (en) * 2010-01-15 2011-07-21 Mount Sinai School Of Medicine Inhibition of tnf-alpha induced activation of nfkb by pentosan polysulfate
WO2012101544A1 (en) * 2011-01-29 2012-08-02 Alembic Pharmaceuticals Limited An improved process for the preparation of pentosan polysulfate or salts thereof
WO2012114349A1 (en) * 2011-02-23 2012-08-30 Cadila Healthcare Limited An improved process for the preparation of pentosan polysulfate sodium

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH290145A (de) * 1944-06-13 1953-04-15 Kaulla Kurt Nikolai Dr Med Von Verfahren zur Herstellung von Schwefelsäureestern des Xylans.
FR1050576A (fr) * 1951-02-06 1954-01-08 Wander Ag Dr A Procédé pour la préparation de sels alcalins de l'ester sulfurique du xylane
US3290263A (en) * 1962-08-02 1966-12-06 Colonial Sugar Refining Co Process of reacting sugars with reagents wherein the sugar is dissolved in monohydric alcohols containing grouping
ES343957A1 (es) * 1967-08-09 1968-10-01 Rocador Sa Procedimiento de obtencion de polisacaridos sulfatados an- tilipemicos activos por via oral.
US4098995A (en) * 1976-07-12 1978-07-04 American Cyanamid Company Polygalactosido-sucrose poly(h-)sulfate salts
US4301153A (en) * 1977-03-21 1981-11-17 Riker Laboratories, Inc. Heparin preparation
US4122250A (en) * 1977-08-22 1978-10-24 Gottfried Schmer Separation of high-activity heparin by affinity chromatography
US4221907A (en) * 1979-07-09 1980-09-09 American Cyanamid Company Substituted O-α-D and O-β-D-multi-galactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6 α-D-glucopyranoses
DE2945595A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Verfahren zur herstellung von niedermolekularem heparin bzw. seinen salzen
US4281108A (en) * 1980-01-28 1981-07-28 Hepar Industries, Inc. Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
FR2543145B1 (fr) * 1983-03-24 1986-10-17 Sanofi Sa Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11286272B2 (en) 2016-08-31 2022-03-29 Oji Holdings Corporation Production method for acidic xylooligosaccharide, and acidic xylooligosaccharide
US11312790B2 (en) 2016-08-31 2022-04-26 Oji Holdings Corporation Production method for pentosan polysulfate
US11274165B2 (en) 2017-02-28 2022-03-15 Oji Holdings Corporation Pentosan polysulfate, pharmaceutical composition, and anticoagulant
US11278485B2 (en) 2017-05-31 2022-03-22 Oji Holdings Corporation Moisturizing topical preparation
WO2019054344A1 (ja) * 2017-09-12 2019-03-21 王子ホールディングス株式会社 ポリ硫酸ペントサン及びポリ硫酸ペントサンの製造方法
JPWO2019054344A1 (ja) * 2017-09-12 2020-10-15 王子ホールディングス株式会社 ポリ硫酸ペントサン及びポリ硫酸ペントサンの製造方法
US11390693B2 (en) 2017-09-12 2022-07-19 Oji Holdings Corporation Pentosan polysulfate and method for producing pentosan polysulfate
WO2019124363A1 (ja) * 2017-12-20 2019-06-27 王子ホールディングス株式会社 ポリ硫酸ペントサン及びポリ硫酸ペントサンを含む医薬
JPWO2019124363A1 (ja) * 2017-12-20 2020-04-02 王子ホールディングス株式会社 ポリ硫酸ペントサン及びポリ硫酸ペントサンを含む医薬
KR20200099533A (ko) * 2017-12-20 2020-08-24 오지 홀딩스 가부시키가이샤 폴리황산펜토산 및 폴리황산펜토산을 포함하는 의약
AU2018387999B2 (en) * 2017-12-20 2021-06-17 Oji Holdings Corporation Pentosan polysulfate and medicine containing pentosan polysulfate
US11344570B2 (en) 2017-12-20 2022-05-31 Oji Holdings Corporation Pentosan polysulfate and medicine containing pentosan polysulfate

Also Published As

Publication number Publication date
NZ207622A (en) 1986-08-08
DE3461808D1 (en) 1987-02-05
IL70846A0 (en) 1984-05-31
ZA842176B (en) 1984-10-31
EP0125152B1 (fr) 1986-12-30
KR840008376A (ko) 1984-12-14
US4699900A (en) 1987-10-13
AU561588B2 (en) 1987-05-14
DK55784A (da) 1984-09-25
ES530266A0 (es) 1984-11-01
ES8500962A1 (es) 1984-11-01
CA1221090A (fr) 1987-04-28
KR860001394B1 (ko) 1986-09-22
DK55784D0 (da) 1984-02-08
AU2441284A (en) 1984-09-27
FR2543145A1 (fr) 1984-09-28
FR2543145B1 (fr) 1986-10-17
EP0125152A1 (fr) 1984-11-14
ATE24520T1 (de) 1987-01-15
PT78179B (fr) 1986-04-24
GR79831B (en, 2012) 1984-10-31
PT78179A (fr) 1984-04-01

Similar Documents

Publication Publication Date Title
JPS6063203A (ja) 新規なキシランスルフエ−ト，その製法並びにその抗血栓症および血中脂肪低下活性
JPS61197601A (ja) 新規な低分子量の硫酸キシラン、その製造法およびそれを含む医薬品
US4533549A (en) Antithrombotic agent
CA1136620A (en) Heparin fragments having selective anticoagulation activity
JPS59133202A (ja) 解重合及び超硫酸化ヘパリン、その製造方法並びに製薬組成物
CS366891A3 (en) N,o-sulfated heparosanes, process of their preparation and pharmaceuticalcompositions containing said n,o-sulfated heparosanes
JPS6227402A (ja) グリコサミノグリカンの硫酸化方法、該方法によつて得られる新規グリコサミノグリカン及びその生物学的適用
EP1070503A1 (en) Compositions comprising very low molecular weight Heparin
US5519010A (en) Sulfated polysaccharide, pharmaceutically acceptable salt thereof, process for preparing same and medicament containing same as effective component
KR910006811B1 (ko) 고-순도 더마탄 설페이트의 제조방법
WO1992002232A1 (en) Heparin fragment showing complement inhibition activity
Yan et al. Highly purified fucosylated chondroitin sulfate oligomers with selective intrinsic factor Xase complex inhibition
WO2013131406A1 (zh) 解聚海参糖胺聚糖在制备防治血栓栓塞疾病药物中的应用
EP0137356A2 (en) Covalently bound heparin - antithrombin-III complex, method for its preparation and its use for treating thromboembolism
DK172798B1 (da) Fremgangsmåde til fremstilling af lavmolekylære hepariner ved depolymerisation af normal heparin
JPH04288301A (ja) エポキシヘパリドの製法、その生成物及びそれらを含む医薬組成物
US5268366A (en) Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient
EP0408770B1 (en) New sulfated polysaccharide, pharmaceutically acceptable salts thereof, preparation thereof, and drug containing the same as active ingredient
CN101605549A (zh) 包括至少一个与生物素或生物素衍生物的共价键的肝素、其制备和用途
CN114533756A (zh) 硫酸葡半乳寡聚糖在制备抗凝血和/或抗血栓药物中的应用
Sache et al. Partially N-desulfated heparin as a non-anticoagulant heparin: some physico-chemical and biological properties
US20110263527A1 (en) Sulfated Galactans With Antithrombotic Activity, Pharmaceutical Composition, Method for Treating or Prophylaxis of Arterial or Venous Thrombosis, Method of Extraction and Use Thereof
US9056118B2 (en) Extract for preventing of treating thrombotic diseases
JPS63235301A (ja) ヘパリノイド活性を有する多糖体及びその製造方法並びにそれを含有する抗血液凝固剤
JPH0532703A (ja) 低分子量ヘパリン誘導体の製造法